Barclays PLC Deciphera Pharmaceuticals, Inc. Transaction History

Barclays PLC

  • $377 Billion
  • Q3 2024

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$13.58 - $17.36 $1.04 Million - $1.33 Million
-76,592 Reduced 46.39%
88,521 $1.39 Million
Q4 2023

Feb 15, 2024
BUY
$10.11 - $16.54 $516,337 - $844,730
51,072 Added 44.78%
165,113 $2.66 Million
Q3 2023

Nov 07, 2023
SELL
$12.46 - $15.48 $343,322 - $426,535
-27,554 Reduced 19.46%
114,041 $1.45 Million
Q2 2023

Aug 03, 2023
BUY
$13.28 - $15.96 $212,825 - $255,774
16,026 Added 12.76%
141,595 $1.99 Million
Q1 2023

May 04, 2023
SELL
$14.26 - $22.1 $609,900 - $945,217
-42,770 Reduced 25.41%
125,569 $1.94 Million
Q4 2022

Feb 13, 2023
BUY
$14.85 - $19.04 $179,818 - $230,555
12,109 Added 7.75%
168,339 $2.76 Million
Q3 2022

Nov 03, 2022
BUY
$12.38 - $20.23 $1.41 Million - $2.31 Million
114,082 Added 270.67%
156,230 $2.89 Million
Q2 2022

Aug 12, 2022
SELL
$9.11 - $13.98 $1.26 Million - $1.93 Million
-138,226 Reduced 76.63%
42,148 $554,000
Q1 2022

May 16, 2022
BUY
$6.87 - $11.11 $275,425 - $445,411
40,091 Added 28.58%
180,374 $1.67 Million
Q4 2021

Feb 14, 2022
BUY
$7.7 - $37.13 $590,620 - $2.85 Million
76,704 Added 120.64%
140,283 $1.37 Million
Q3 2021

Nov 09, 2021
BUY
$26.46 - $37.15 $878,101 - $1.23 Million
33,186 Added 109.19%
63,579 $2.16 Million
Q2 2021

Aug 13, 2021
SELL
$32.73 - $47.95 $1.96 Million - $2.88 Million
-59,974 Reduced 66.37%
30,393 $1.11 Million
Q1 2021

May 13, 2021
BUY
$40.39 - $56.73 $1.5 Million - $2.1 Million
37,057 Added 69.51%
90,367 $4.05 Million
Q4 2020

Feb 11, 2021
BUY
$51.77 - $66.18 $1.69 Million - $2.16 Million
32,563 Added 156.95%
53,310 $3.04 Million
Q3 2020

Nov 12, 2020
SELL
$43.8 - $58.16 $965,921 - $1.28 Million
-22,053 Reduced 51.53%
20,747 $1.06 Million
Q2 2020

Aug 12, 2020
SELL
$37.05 - $65.03 $560,196 - $983,253
-15,120 Reduced 26.1%
42,800 $2.56 Million
Q1 2020

May 13, 2020
BUY
$33.63 - $69.4 $891,598 - $1.84 Million
26,512 Added 84.41%
57,920 $2.39 Million
Q4 2019

Feb 10, 2020
SELL
$31.7 - $69.93 $67,838 - $149,650
-2,140 Reduced 6.38%
31,408 $1.96 Million
Q3 2019

Nov 14, 2019
BUY
$19.95 - $38.85 $478,141 - $931,117
23,967 Added 250.15%
33,548 $1.14 Million
Q2 2019

Aug 14, 2019
SELL
$21.05 - $26.21 $10,146 - $12,633
-482 Reduced 4.79%
9,581 $216,000
Q1 2019

May 15, 2019
SELL
$20.65 - $29.55 $79,399 - $113,619
-3,845 Reduced 27.65%
10,063 $234,000
Q4 2018

Feb 14, 2019
BUY
$19.08 - $36.14 $173,112 - $327,898
9,073 Added 187.65%
13,908 $292,000
Q3 2018

Nov 14, 2018
BUY
$33.57 - $42.1 $124,410 - $156,022
3,706 Added 328.26%
4,835 $188,000
Q2 2018

Aug 14, 2018
SELL
$20.06 - $44.95 $62,506 - $140,064
-3,116 Reduced 73.4%
1,129 $44,000
Q1 2018

May 15, 2018
BUY
$20.04 - $29.71 $58,857 - $87,258
2,937 Added 224.54%
4,245 $86,000
Q4 2017

Feb 14, 2018
SELL
$16.54 - $24.2 $391,865 - $573,346
-23,692 Reduced 94.77%
1,308 $30,000
Q3 2017

Nov 14, 2017
BUY
$17.65 - $18.99 $441,249 - $474,749
25,000
25,000 $475,000

Others Institutions Holding DCPH

# of Institutions
6
Shares Held
293K
Call Options Held
500
Put Options Held
0
View Full List

About Deciphera Pharmaceuticals, Inc.

DCPH Quotes by TradingView
  • Ticker DCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,822,100
  • Description
  • Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...
More about DCPH
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email